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In postnatal developing optic nerves, astrocytes organize their processes in a cribriform network to group axons into bundles. In neonatal
rat optic nerves in vivo, the active form of EGFR tyrosine kinase is abundantly present when the organization of astrocytes and axons is most
actively occurring. Blocking activity of EGFR tyrosine kinase during the development of rat optic nerves in vivo inhibits astrocytes from
extending fine processes to surround axons. In vitro, postnatal optic nerve astrocytes, stimulated by EGF, organize into cribriform structures
which look remarkably like the in vivo structure of astrocytes in the optic nerve. In addition, when astrocytes are co-cultured with neonatal rat
retinal explants in the presence of EGF, astrocytes that are adjacent to the retinal explants, re-organize to an astrocyte-free zone into which
neurites grow out from the retinal tissue. We hypothesize that in the developing optic nerve, EGFR activity directs the formation of a
histoarchitectural structure of astrocytes which surrounds axons and provides a permissive environment for axon development.
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In the developing central nervous system, the epidermal
growth factor receptor (EGFR) plays a critical role. EGFR is
linked to the mitotic responsiveness and the cell fate choice
of neuroprogenitors (Burrows et al., 1997; Lillien and
Raphael, 2000; Lillien and Wancio, 1998), neurogenesis
(Blum, 1998), and astrogliogenesis (Rabchevsky et al.,
1998). During late embryonic development, EGFR acts as
an astrocyte-inducing signal to promote astrocyte develop-
ment (Burrows et al., 1997), perhaps by regulating the
responses of progenitors to extrinsic signals, such as leuke-
mia inhibitory factor (Viti et al., 2003). Specific populations
of cells, for example in the telencephalon, migrate in
response to EGFR ligands by a chemoattractive mechanism
(Caric et al., 2001). EGFR ligands, such as TGFa and EGF,0012-1606/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
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(Wildering et al., 2001).
Depending on the genetic background (Kornblum et al.,
1998; Miettinen et al., 1995, 1999; Sibilia and Wagner,
1995; Threadgill et al., 1995), Egfr knockouts are embry-
onically lethal, die in the neonatal period due to severe
immaturity of several epithelial organs, or survive for a time
postnatally but develop severe degenerations of the olfac-
tory bulb, neocortex, and cerebellum. The neurodegenera-
tion in the Egfr/ mice is characterized by massive cell
apoptosis involving both neurons and astrocytes (Kornblum
et al., 1998; Sibilia et al., 1998). In developing Egfr/
mice, astrocytes do not migrate into the cortex (Kornblum et
al., 1998), consistent with the suggestion that EGFR acti-
vation signals developmental functions in astrocytes.
Our previous work found that activation of EGFR
dramatically changes the morphological characteristics and
gene expression of cultured astrocytes (Liu and Neufeld,
2004). EGF-treated adult rat and human optic nerve astro-
cytes in vitro form cribriform structures, which are similar to
the histological structure of astrocytes in optic nerve heads
in vivo. Based on these findings, we hypothesized that the
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astrocytes in optic nerves during development.
As ocular development proceeds, optic cup and optic
stalk develop into retina and optic nerve, respectively
(Kuwabara, 1975). The first axons of the retinal ganglion
cells exit the eye into the optic stalk through an opening at
its base where the choroid fissure develops. Neuroepithelial
cells of the optic stalk give rise to the first optic nerve glial
cells and to cells lining the choroid fissure. The retina on
either side of the choroid fissure enlarges and fuses to form
the optic disk. The neuroepithelial cells around the optic
disk extend into the optic nerve head and guide axons into
the optic nerve (Oster and Sretavan, 2003; Stuermer and
Bastmeyer, 2000). The determination and functions of these
neuroepithelial cells are influenced by Pax-2, Shh, netrin-1,
and members of the Slit family (Dakubo et al., 2003;
Lemke, 2001; Macdonald and Wilson, 1996; Macdonald
et al., 1995). The neuroepithelial cells, driven by bFGF,
divide and differentiate into GFAP-positive astrocytes in the
optic nerve by E19 (Mi and Barres, 1999).
Retinal ganglion cells first project axons through glial
channels on the retinal surface before reaching the optic
stalk on E14 (Sefton et al., 1985). The axonal connections of
the retinal ganglion cells are made to the brain and are
dependent on axon guidance molecules in the later stages of
optic nerve development in most mammals (Dallimore et al.,
2002). At birth, the optic nerve contains approximately
twice the number of axons of the adult animal. During the
first week of birth, astrocytes extend processes to separate
axon bundles and over 50% of the axons degenerate (Crespo
et al., 1985). Myelination of the axons posterior to the optic
nerve head begins on day P5 and continues until the end of
the second postnatal week (Kuwabara, 1975). About the
same time, an astrocyte lattice develops in the retina
mediated by platelet-derived growth factor (Fruttiger et al.,
1996). By the end of the 3rd postnatal week, the rat optic
nerve is developed into its adult form.
In the present studies, we have found that EGFR is
highly expressed and activated in optic nerve head astro-
cytes in the late stage of optic nerve development in rats.
Blocking EGFR function postnatally causes significant
disorganization of astrocytes and axons in the optic nerve.
Our findings support the hypothesis that the EGFR signal
pathway directs the formation of a histoarchitectural struc-
ture of astrocytes that is needed for the proper maintenance
and organization of axons as the optic nerve nears the end of
its developmental period.Materials and methods
Immunohistochemistry of perinatal optic nerve development
Developing pups of Wistar rats were sacrificed at em-
bryonic day 19 and at postnatal days: 1, 3, 6, 9, 14, 17, or
21. Six eyes from three rats at each time point wereprocessed for histology or immunohistochemistry. The eyes
were enucleated and fixed in 4% paraformaldehyde. The
optic nerves were dissected free of surrounding tissues.
Fixed tissue was washed in 0.2% glycine in phosphate-
buffered saline (PBS), pH 7.4, dehydrated, embedded in
paraffin, and oriented for 6 Am sagittal or cross-sections.
Cross-sections of the optic nerves were cut anterior (the area
proximate to the eye sclera layer). Three sections per eye
were randomly chosen for standard H&E staining for
observation of histological structure. The neighboring slides
of each of the three sections were used for immunohisto-
chemical studies.
The paraffin tissue sections were deparaffined, rehydrated,
and washed completely with 0.1 M glycine–Tris solution. To
block nonspecific binding, the tissue sections were pre-
incubated with 20% donkey serum at room temperature for
30min. Immunohistochemistry was performed using specific
primary antibodies against p-EGFR (Santa Cruz Biotechnol-
ogy Inc, Santa Cruz, CA; goat polyclonal, working dilution
1:200), glial fibrillary acidic protein (GFAP) (Chemicon
International, Temecula, CA, mouse monoclonal, working
dilution 1:200), EGF (goat polyclonal, working dilution
1:100) and TGFa (rabbit polyclonal, working dilution
1:25), tau (goat polyclonal, working dilution 1:150) (Santa
Cruz Biotechnology Inc) or neurofilament (SMI-31, Stern-
berger Monoclonals Inc, Lutherville, MD; working dilution
1:800) and the Vectastain Elite ABC kit (Vector Labs,
Burlingame, CA), using diaminobenzidine as substrate. He-
matoxylin was the counter stain. Negative controls were
performed in parallel by pre-incubation of the primary
antibody at 4jC overnight with its specific blocking peptide.
Immunoblots
Rat optic nerve tissues were dissected from the eye globe
to the optic chiasma and obtained from two to three pups of
one litter at postnatal days: 1, 3, 6, 9, 14, and 21. Three
different litters of animals were used. Rat optic nerve tissues
were lysed in buffer (20 mM HEPES, pH 7.0, 10 mM KCl,
2 mM MgCl2, 0.5% Nonidet P40, 1 mM Na3VO4, 1 mM
PMSF, 0.15 U ml1 aprotinin) and homogenized. Protein
concentration was determined using the Bradford colorimet-
ric assay. Twenty micrograms of each protein lysate were
loaded in each lane in sample buffer (2% SDS, 10%
glycerol, 0.001% bromophenol blue, 1% DTT, and 0.05
M Tris–HCl, pH 6.8), separated on 10% SDS-PAGE, and
transferred to a nitrocellulose filter. The blots were blocked
with 5% nonfat milk in PBS and then incubated with
specific rabbit polyclonal antibody against EGFR (Santa
Cruz Biotechnology Inc; working dilution 1:200), p-EGFR
(Santa Cruz Biotechnology Inc, goat polyclonal, working
dilution 1:100), GFAP (Sigma-Aldrich Corp, St Louis, MO;
rabbit polyclonal, working dilution 1:2000), neurofilament
(SMI-31, Sternberger Monoclonals Inc; mouse monoclonal,
working dilution 1:2000) or actin (Sigma-Aldrich Corp.,
mouse monoclonal, working dilution 1:5000) followed by
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hanced chemiluminescence detection system (Amersham
Life Science Inc, Arlington Heights, IL).
Administration of AG1478 in vivo
After birth, all pups were weighed, divided into four
groups and marked for identification. One group (n = 12)
was treated daily with AG1478, a very potent and selective
inhibitor of EGFR (Ellis et al., 2001; Liu et al., 1999), at a
dose of 50 mg/kg (Rice et al., 1999) in DMSO vehicle by
subcutaneous injection, a group of pups was treated similarly
at a dose of 5 mg/kg AG1478, a group (n = 12) was treated
similarly with the DMSO vehicle, and a group (n = 12) was
untreated. The animals were weighed daily and closely
followed. Four different litters of rats were used. At 10 or
21 days postnatal, six animals of each group were sacrificed.
For each rat, one optic nerve was processed as paraffin cross-
sections for histology using H&E or for immunohistochem-
istry using antibodies against pEGFR, GFAP, or neurofila-
ment (SMI-31) as described above, and the other optic nerve
was processed for electron microscopic examination.
Electron microscopic examination
Optic nerves including the posterior eyes were carefully
dissected and fixed in 2% paraformaldehyde and 2.5%
glutaraldehyde in 0.1 M phosphate buffer. The tissues were
postfixed in 1% osmium tetroxide for 1 h at 4jC. After
further trimming and orientation under a dissecting micro-
scope, the small pieces were dehydrated in a graded series of
ethyl alcohol (50–100%), embedded in an Epon 812 and
Araldite 6005 mixture and oriented for cross-sections of
optic nerves. Thick (0.5–1.0 Am) sections were stained with
alkaline toluidine blue for light microscopic observation to
locate the section-cutting level of the optic nerve at the area
proximate to the scleral layer. Ultrathin (70–80 nm) sections
were placed on a 2  1 nm cooper grids and stained with
uranyl acetate and lead citrate. Sections were examined
using a transmission electron microscope (Hitachi H-7500).
Cell cultures
Rat optic nerve astrocytes were derived from the anterior
portions of the rat optic nerve from six Wistar rats on
postnatal day 10 (Charles River, Chicago, IL) by the same
procedure as for human optic nerve astrocytes as described
previously (Hernandez et al., 1988). The posterior pole of
the eye was dissected and the optic nerve head was freed
from sclera and other neighboring tissues. The optic nerve
head was sliced sagittally, and under a dissecting micro-
scope, the anterior portion of the optic nerve was carefully
dissected from the pre- and post-laminar regions. From each
eye, two or three explants were obtained. The explants were
put into T 25 cm2 plastic tissue culture flasks, which had
been conditioned with DMEM/F-12 supplemented with10% fetal bovine serum. The first passage cells were
characterized by immunostaining of GFAP and neural cell
adhesion molecule and other cellular markers (HLA-DR, a-
smooth muscle actin and von Willebrand factor) to distin-
guish them from other cell types from the optic nerve. The
primary cell cultures were purified for astrocytes by grow-
ing the cells for 1 week in modified astrocyte-defined,
serum-free medium (ADM, Clonetics) containing forskolin,
which suppresses the growth of fibroblasts. The second-
passage cell cultures, which had over 95% cells positive for
GFAP, were grown to 60–80% confluency and serum-
starved in ADM for 1 week before being used for the
following experiments.
EGF (final concentration 10 or 100 ng/ml) (Kubota et al.,
2001) (Sigma-Aldrich Corp.) was added to the cell media
for 12, 24, 48, 72 h, or 6 days.
Astrocyte/retinal explant co-cultures
Rat optic nerve astrocytes were grown on coverslips to
confluency and serum-starved for 3–7 days. Retinal
explants were obtained from neonatal (P2) Wistar rats. After
rats were anesthetized, the eyes were removed and the
retinas were dissected from surrounding tissues in cold
DMEM/F-12 cell media. The isolated retinas were carefully
cut into approximately 1 mm2 pieces by sharp blades. The
retinal explants were attached to the astrocyte monolayer
with the retinal ganglion cell layer facing the astrocytes.
Appropriate amounts of cell growth media DMEM/F-12
without serum were added to immerse the astrocytes and the
retinal explants but to not float the explants. Retinal explants
were also placed on poly-L-lysine coated coverslips as
controls. When present, EGF (100 ng/ml) was added to
the cell growth media when retinal explants were placed
into the culture media. The cultures were maintained at
37jC in 5% CO2/air in an incubator for 3 days.
Immunocytochemistry
The co-cultures were fixed in 4% paraformaldehyde and
processed for immunocytochemistry for neurofilaments
(SMI-31, working dilution 1:200), tau (Santa Cruz Biotech-
nology Inc; goat polyclonal, working dilution 1:50), GFAP
(rabbit polyclonal, working dilution 1:50) or phalloidin
(Molecular Probes, Eugene, OR; Rhodamine red-X conju-
gated, working dilution 1:50). Double-staining for tau and
phalloidin was used to show the histoarchitecture of the co-
cultures. As described previously (Liu and Neufeld, 2000),
cells grown on coverslips were fixed in 4% paraformalde-
hyde at 4jC for 30 min, washed in PBS and treated with
0.5% FBS/0.2% Triton X-100/0.5% glycine in PBS for 20
min. The coverslips were incubated with specific primary
antibodies. After washing several times with PBS, the
coverslips were incubated with appropriate secondary anti-
body. For double immunofluorescent staining, the cover-
slips were sequentially incubated with the second primary
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After washing several times with PBS, the coverslips were
mounted in ProLong (Molecular Probes Inc.). Secondary
antibodies: goat anti-mouse Oregon green (1:400), goat anti-
rabbit Rhodamine red-X conjugated IgG (1:1000), horse
anti-goat FITC-X conjugated IgG (1:50) were purchased
from Molecular Probes.
Slides were observed and photographed using a micro-
scope (Olympus AX70, Tokyo, Japan) equipped with a
digital camera (Spot, Diagnostic Instruments Inc., Sterling
Heights, MI).
Neurite growth zone analysis
After hematoxylin–eosin (H&E) staining, the retinal
explants were photographed using a 1.25 lens on a
microscope equipped with a digital camera. Using Optimas
6.2 image analysis software, the micrographs of the retinal
explants were measured and quantitated for the area of the
zone covered by the growing neurites. The area of the
neurite growth zone was normalized to the perimeter of
the retinal explant. Twelve explants for each experimental
condition and control group from each of three independent
experiments were measured. All data were statistically
analyzed using Student’s t test.Results
Activated EGFR in the developing rat optic nerve head
To obtain a temporal sequence of the activation of EGFR
and the histological structure of the developing optic nerve
head, a series of embryonic and postnatal (from day E19 to
P21) rat optic nerve head sections were studied for activated
EGFR (p-EGFR), EGFR ligands (EGF and TGFa), struc-
ture of astrocytes (GFAP), and maturity of axons (neuro-
filament SMI-31).
In optic nerve heads of day E19, cells were dispersed
randomly throughout the tissue. Labeling for GFAP was
weak, indicating that the glial precursor cells had not fully
matured to be GFAP-positive astrocytes (Fig. 1A). Labeling
for p-EGFR showed that the cells in the optic nerve head
had minimal levels of the active form of EGFR (Fig. 1B).
EGF was not detectable (Fig. 1C); however, labeling for
another EGFR ligand, TGFa, was weakly positive in the cell
bodies (data not shown). Labeling for neurofilaments was
negative in optic nerves of day E19 (Fig. 1D).
Observations on sequential tissue sections of optic nerve
heads from day E19, P1, P3, and P6 demonstrated that the
level of p-EGFR and EGF gradually increased and GFAP-
positive labeling became more intense. In optic nerve heads
of day P6, cells had increased in number and were intensely
labeled for GFAP. The GFAP-positive astrocytes formed a
cribriform network with a fine lattice of astrocyte processes
in the optic nerves on day P6 (Fig. 1E). At the same time,abundant labeling for p-EGFR was present (Fig. 1F) and
EGFR ligands, EGF (Fig. 1G) and TGFa, (data not shown)
were also abundantly detected in the cell bodies. However,
the labeling for neurofilament was negative (Fig. 1H). The
labeling for GFAP, p-EGFR, and EGFR ligands gradually
decreased in intensity in the optic nerves through days P9 to
P21. At day P9 when a full complement of axons is known
to be present in the optic nerve, neurofilament SMI-31 was
minimally detectable. Thereafter, neurofilament SMI-31
increased in amount, filling the spaces between the cribri-
form network of astrocytes.
On day P21, the optic nerves were densely packed with
cells but the labeling for GFAP in the astrocytes was
moderate (Fig. 1I) and the labeling for p-EGFR was faint
(Fig. 1J). The labeling for EGF was weak and mainly in the
cells near capillaries (Fig. 1K). On day P21, labeling for
neurofilament SMI-31 was very intense and appeared as
bundles in the cross-sections of optic nerve heads (Fig. 1L).
These neurofilaments, which were detected in axons at the
later stage of optic nerve development, apparently demon-
strate mature axons.
These immunohistochemical results were confirmed by
immunoblot (Fig. 2). The intensity of the immunoblot
bands for GFAP gradually increased after birth, peaking
on P6-P9 and then decreased to a moderate level after
P14. By immunoblot, p-EGFR was detected on P1, highly
increased in amount on P3 and P6, and became undetect-
able after P9. Although both the immunohistochemical
and immunoblot studies for p-EGFR indicated that EGFR
was highly phosphorylated around P6, an intense immu-
noblot band for EGFR was detected in the optic nerves on
P1 and the protein levels of EGFR gradually decreased
through P3 to P9, becoming barely detectable after P14.
Neurofilaments were not detectable on P1, but were
clearly detected on P9 and became abundant on P21.
Our studies using immunoblot and immunohistochemistry
show that the activation of the EGFR was concurrent with
the formation of the fine cribriform network of astrocytes
in the postnatal developing rat optic nerves. The appear-
ance of neurofilament SMI-31, as a marker for the
maturity of the cytoskeleton of axons, was sequentially
later than the peak time of the activation of EGFR and the
organization of the cribriform structure of astrocytes in the
developing optic nerve.
Activation of EGFR causes organization of postnatal
astrocytes into cribriform structures in vitro resembling
the tissue structure of astrocytes in optic nerves in vivo
Previously, we demonstrated that adult astrocytes from
rat optic nerve heads elongate and form cribriform
structures with cell-free spaces in response to activation
of EGFR in vitro (Liu and Neufeld, 2004). To confirm
these observations in astrocytes from developing optic
nerves, we cultured astrocytes from optic nerves of day
P10 rats. In the absence of exogenous EGF, rat optic
Fig. 1. Perinatal development of the rat optic nerve. Immunolabeling for GFAP (A, E, and I), p-EGFR (B, F, and J), EGF (C, G, and K), and neurofilament (D,
H, and L). On day E19, cells of the astrocyte lineage are dispersed randomly throughout the tissue. The cells are GFAP-negative (A) but perhaps p-EGFR-
positive (B, arrows). EGF is not detectable (C). There is no positive labeling for neurofilament in the optic nerve on day E19 (D). On day P6, a cribriform
network of intensely GFAP-positive astrocytes has formed (E) and the cells are positive for p-EGFR (F, arrows) and EGF (G). A fine lattice of GFAP-positive
astrocyte processes is present in the optic nerve tissue. Labeling for neurofilament is not detected on day P6 (H). On day P21, the optic nerve is densely packed
with moderately positive GFAP-positive astrocytes (I) that are weakly labeled for p-EGFR (J, arrows) and EGF (K). The axons filling the spaces between the
network of astrocytes have intensive labeling for neurofilament (L). All cross-sections were stained with HRP/DAB and counterstained with hematoxylin.
Magnification: 600.
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polygonal and formed a monolayer. Very few astrocytes
were elongated (Fig. 3A).
The morphology of optic nerve P10 astrocytes
changed significantly after addition of EGF to the media.
Within 12 h, the cells became elongated with very long,
thin processes that crossed over several neighboring cells.
A few astrocytes remained flat and polygonal in shape.
In addition to the shape changes, the astrocytes gradually
lost the monolayer arrangement to form a cribriform
architecture. Within 12–24 h of the initial exposure to
EGF, the astrocytes appeared to stretch out further in the
direction of their long processes. Gradually, the elongated
astrocytes piled up in local areas, developed interlaced
processes and circumferentially surrounded cell-free
spaces. After 3 days of treatment with EGF, the astro-
cytes throughout the culture dish clearly reorganized to
produce a cribriform structure that had multilayers ofelongated astrocytes interweaving their processes to form
a network surrounding large cell-free spaces (Fig. 3B).
Comparing the in vitro architecture of EGF-treated
astrocytes (Fig. 3B) to the in vivo histological organization
of astrocytes (Fig. 1E), there were striking similarities in
morphology between the cribriform structure formed by
EGF-treated, P10 astrocytes in vitro and the postnatal
organization of astrocytes in optic nerve heads in vivo.
Inhibition of EGFR activity caused defects in the postnatal
development of both astrocytes and axons
To demonstrate the function of EGFR in developing
optic nerves, we performed pharmacological experiments
to determine whether inhibition of activation of EGFR
would alter development. We used AG1478, a specific
inhibitor of EGFR tyrosine kinase, which has been used
Fig. 2. Immunoblots for GFAP, EGFR, p-EGFR, and NF from perinatally
developing optic nerve tissues. Immunoblot bands for GFAP was most
intense on P6. The intensity of the immunoblot bands for EGFR was very
high at birth and gradually decreased. p-EGRR is present on P1, increased
on P3 and P6, and decreased after P9. NF was not detectable at birth but
gradually increased from P9 to P21. Actin is the internal loading control.
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treated with AG1478 at 5 mg/kg for the 3-week postnatal
period appeared to gain weight and to develop normally.
Pups treated with AG1478 at 50 mg/kg gained less weight
than controls and were not examined further.
Electron microscopic examinations of cross-sections of
optic nerve heads of AG1478-treated rats revealed sig-
nificant deficiencies of the cellular network of astrocytes
and abnormalities of axons when compared with normal
rats. At P1, before treatment with AG1478, optic nerves
had already fully filled with small diameter axons, which
were separated into large bundles by thick processes of
astrocytes (data not shown). In normal, developing optic
nerve heads at P10, astrocytes had extended branches
into axons to group the axons into bundles (Fig. 4A);
however, within each axon bundle, many axons were
tightly packed together without separation by fine pro-
cesses of astrocytes (Fig. 4B). On the cross-sections of
normal optic nerves at P10, the diameters of axons varied
and appeared increased in size compared with that on P1.
The astrocytes contained numerous filaments, microtu-
bules, and various microorganelles.
In AG1478-treated rats at P10, there were abundant
vacuolated spaces in axon bundles (Fig. 4C). VacuolationFig. 3. Effects of EGFR activation of rat optic nerve astrocytes. Primary cultures o
(B) EGF for 3 days. EGF causes rat astrocytes to elongate and to form cri
Magnification: A, B, 100.of axons appeared as large empty spaces without internal
structures inside the nerve bundles (Fig. 4D) and also was
observed inside individual axons (Fig. 4E), which indicat-
ed abnormal, perhaps degenerating axons. The vacuolated
spaces in axon bundles were observed in the optic nerves
of all AG1478-treated rats on P10 by electron microscopy.
In addition, there were fewer processes of astrocytes in the
optic nerve heads of AG1478-treated rats and the astro-
cytic processes were irregular compared to normal optic
nerve heads at P10.
In normal optic nerve heads at P21, the fine network
of astrocytes was formed. Astrocytes extended long, thin
processes to further group axons into bundles (Fig. 4F).
Inside the axon bundles, astrocytes had extended
branches of very fine processes to surround the axons
(Fig. 4G). By the shape of axons in the cross-section,
axons appeared regularly aligned with straight paths.
However, in the optic nerve heads of AG1478-treated
rats at P21, the astrocyte network and the axons were
disorganized. The processes of astrocytes were short,
thick, and lacked filaments. Axons were not regularly
grouped into bundles by fine processes of astrocytes (Fig.
4H). Furthermore, the axons had irregular shapes on
cross-sections of the optic nerves (comparing Figs. 4H
and F). We did not observe vacuolated spaces in nerve
bundles in the AG1478-treated optic nerve heads at P21
as were present at P10.
By light microscopy, defects of astrocytes and axons are
also demonstrated in the optic nerve heads of AG1478-
treated rats. On postnatal day 1, when rat pups were started
on the treatment with AG1478, astrocytes have formed an
initial sparse network and axons were grouped into very
large bundles in the optic nerves. Nevertheless, postnatal
treatment, starting on P1, with AG1478 significantly af-
fected astrocytes to further develop the fine lacing network
and to group axons into small bundles in the optic nerve
head. Comparing the histological appearances with H&E
staining (Figs. 5A and E, B and G), the fine, lacey
processes of astrocytes are clearly absent in the optic
nerves of the drug-treated animals at P10. Also, in the
optic nerves of AG1478-treated rats at P10, there weref P10 rat optic nerve astrocytes exposed, in vitro, to (A) control conditions,
briform structures surrounding cell-free cavities. Stained with toluidine.
Fig. 4. Electron microscopic observations of effects of inhibition of EGFR activation on the postnatal optic nerve development. On P10, normal optic nerves (A
and B) are fully packed with axons, which are grouped by astrocytes with thick processes. Large numbers of axons are grouped together without separation by
fine processes of astrocytes (B). In the optic nerves of AG1478-treated rats on P10 (C, D, and E), astrocytes appear to have extended fewer processes. Many
empty spaces (*) without axon structures were in the axon bundles. Vacuolation is observed inside individual axons (E, arrow). In normal optic nerves on P21
(F and G), the network of astrocytes is further formed. Astrocytes extend processes to group axons into small axon bundles and also extend very fine processes
to surround individual axons in the axon bundles (G). In the optic nerves of AG1478-treated rats on P21 (H), astrocytic processes are disorganized and axons
are not grouped into small bundles by fine processes of astrocytes. Arrowheads, astrocyte processes.
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labeling for GFAP was moderate and demonstrated that
the astrocytes had fine interlacing cell processes (Fig. 5C).In AG1478-treated animals, the astrocytes were intensely
positive for GFAP in the cell bodies, but there was no
formation of the fine network of astrocytic processes
Fig. 5. Light microscopic observations of effects of inhibition of EGFR activation on the postnatal optic nerve development. In the normal rat optic nerve
histoarchitecture (A, B) on day P10, a fine network of GFAP astrocytic processes (C) has formed and some cells were still positive for p-EGFR (D). The
neurofilaments of the axons of the retinal ganglion cells were sparsely detectable in the optic nerve on P9 (E). When neonatal rats were treated subcutaneously
with AG1478 daily starting on the day of birth and the optic nerves were examined on day P10, there were fewer cells and the fine network of astrocytic
processes had not formed (F). As shown by high magnification (G), the fine interlacing processes of astrocytes were clearly absent. The cells were moderately
positive for GFAP (H), but mostly negative for p-EGFR (I). Most importantly, the neurofilaments of the axons of the retinal ganglion cells were not detectable
on P10 in optic nerves of rat pups treated with AG1478 (J). A and F were stained with H and E; B and G are high magnification images of A and F. C–E and
H–J were labeled with primary antibodies, HRP/DAB and counterstained with hematoxylin. Magnification: A, C–F, H–J 600; B, G 1500.
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in the spaces provided by the network of fine astrocytic
processes in the normal developing optic nerve heads (Fig.
5E). However, labeling for neurofilament was negative on
P10 in the optic nerve heads from AG1478-treated rats
(Fig. 5J). Labeling for p-EGFR confirmed efficacy of
treatment with AG1478 by a much lower level of activa-
tion of EGFR in the AG1478-treated animals (compare
Figs. 5D and I).
These data suggest that activation of the EGFR
pathway is critical for optic nerve head astrocytes to
develop and to organize a fine network of processes and
is needed for the proper maintenance and maturation of
the axons during the postnatal development of the optic
nerve.
EGF stimulated astrocytes re-organize into cell-free spaces
and promote neurite outgrowth
We tested how astrocytes respond to EGF stimulation in
the presence of growing neurites of retinal explants. We
placed neonatal retinal explants on monolayers of optic
nerve astrocytes. The neurites that grow from such retinal
explants are predominantly axons of the retinal ganglion
cells. To identify the cells in the co-cultures, we useddouble-labeling immunocytochemistry for neurofilament
SMI-31 or tau to demonstrate neurites and GFAP or
phalloidin to localize astrocytes.
In co-cultures which were not treated with EGF (Fig. 6A),
although there were astrocytes present initially, and presum-
ably, glia growing from the retinal explant, no neurites
extended from the retinal explant cultured in basic serum-
free media in 3 days. In control cultures in which retinal
explants were placed on poly-L-lysine-coated glass in the
absence of astrocytes, no neurite outgrowth occurred in the
absence of EGF (Fig. 6B) and only modest neurite outgrowth
occurred in the presence of EGF, but the absence of astrocytes
(Fig. 6C).
In the co-cultures of astrocytes and neonatal retinal
explants that were exposed to EGF, astrocytes which
were adjacent to the explants re-organized into a cell-
free zone that circled the explants. In addition, there was
rapid and prodigious growth of neurites from the retinal
explants into the cell-free zone ringed by astrocytes (Fig.
6D). The cell-free zone containing neurites was formed
circumferentially around the explant, between the original
retinal explant and the organized astrocytes, and extended
wider during the 72 h of EGF treatment. At 72 h of
exposure to EGF, the extended neurites from the retinal
explants were curved along the edge of the cell-free zone
Fig. 6. Effect of EGF on the growth of neurites in co-cultures of rat, neonatal retinal explants. Retinal explants with (A) or without (B) astrocytes did not extend
neurites within 72 h of culture. In the presence of EGF but the absence of astrocytes (C), EGF had a modest effect on the extension of growing neurites. In the
presence of EGF and astrocytes (D), retinal explants extended dense networks of growing neurites in 72 h. EGF induced astrocytes to organize an astrocyte-free
zone into which the neurites extended. The neurite growth zone surrounding the entire retinal explant was measured (E), by the following equation: (outer area
of neurite extension)  (area of retina explant) / perimeter of retina explant. Data were calculated from digital photomicrographs by Optimas software. The
neurite growth zone was significantly greater in co-cultures treated with EGF (F, mean F SEM of three experiments). Immunolabeling: green, tau; red,
phalloidin. Magnification: A–D, 200; E, 100.
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tions suggested that under the regulation of the EGFR
pathway, there were attractive signals to promote neurite
outgrowth toward astrocytes and also repulsive signals to
limit the outgrowing neurites to the spaces surrounded by
astrocytes.
In EGF-treated co-cultures of astrocytes and neonatal
retinal explants, the growth of neurites was so great that
we used a surrogate endpoint for quantitation rather than
trying to trace each neurite. To compare the outgrowth ofneurites of experimental and control retinal explants, we
quantitated the ‘‘neurite growth zone’’ as indicated in Fig.
6E. In EGF-treated co-cultures, the neurite growth zone
was significantly greater than the control groups (P < 0.05)
(Fig. 6F). These results, which greatly underestimate the
prodigious neurite outgrowth in response to astrocytes
treated with EGF, nevertheless support the hypothesis that
the activation of EGFR directs astrocytes to surround
axons and to produce a permissive environment for axonal
growth.
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The functional significance of our observations may
relate to a previously unsuspected role for EGFR in the
developing optic nerve. Our results show that late in the
developing optic nerve, the activated EGFR pathway directs
the organization of astrocytes that ultimately affects the
formation of axon bundles. The EGFR signal pathway
may have a similar role in the development of other white
matter regions in the central nervous system.
In the normal development of the rat optic nerve,
activation of EGFR coincides with dramatic morphological
changes in astrocytes. EGFR is present on E19, peaks in the
first postnatal week and remains detectable until the 3rd
postnatal week. During this period, activation of EGFR
occurs and astrocytes complete the histoarchitectural struc-
ture of the fine cribriform network that groups axons into
bundles, and the axons mature. There are significant defects
of the optic nerve when EGFR is inhibited postnatally by a
specific EGFR tyrosine kinase inhibitor, AG1478. In the
optic nerve heads of rats treated with AG1478 postnatally,
astrocytes do not form the fine cribriform network grouping
axons into small bundles and when observed on postnatal
day 10, there are abundant vacuolation spaces in axon
bundles and the axons contain less neurofilaments. Our
results suggest that activation of EGFR is critical for the
formation of the cribriform network of astrocytic processes
surrounding axons and for the maintenance, maturation, and
organization of axons in the later development of the rat
optic nerve.
As shown by immunolabeling for p-EGFR, activation of
EGFR is significantly blocked in the optic nerves of rats
treated with AG1478. Our pharmacological approach ad-
ministered AG1478 to rat pups and may not have complete-
ly inhibited EGFR tyrosine kinase activity in rat optic nerve
heads during the postnatal development. Loss of function of
EGFR has been studied by Egfr gene knockouts. However,
the function of EGFR in the later development of optic
nerves cannot be studied using knock out mice because the
Egfr/ animals are embryonically lethal or have severe
central nervous system malformation due to the critical
functions of EGFR in early embryonic development.
Our in vitro experiments support our hypothesis that
postnatal activation of EGFR causes astrocytes to form a
cribriform network and organize the axons. In vitro, acti-
vation of EGFR induces rat optic nerve astrocytes to form
cribriform structures, which are remarkably similar to the in
vivo tissue structure of astrocytes in optic nerve heads. In
astrocyte/retinal explant co-culture, EGF stimulates the
astrocytes to re-organize and to form cell-free spaces
created adjacent to the retinal explants to provide the path
and space for the outgrowing neurites. In addition, there
was significant promotion of neurite outgrowth by EGF
when astrocytes were present. The interaction between
astrocytes and outgrowing neurites in response to activation
of the EGFR pathway may involve both attractive andrepulsive signals released by astrocytes that affect the
growth cones of neurites.
Our in vitro results were obtained using EGF as the
EGFR ligand. Ligands that bind to EGFR include EGF,
TGFa, epiregulin, h-cellulin, and amphiregulin. We do find
EGF and TGFa in rat perinatal optic nerve tissues by
immunohistochemistry. TGFa knockout mice have abnor-
mal eyes (Luetteke et al., 1993) suggesting that the expres-
sion of EGFR ligands affects the development of the eye. In
addition, many axon guidance molecules, such as netrin (Yu
and Bargmann, 2001), Slit (Rothberg et al., 1990), laminin
(Engel, 1992), and tenascin-C (Saga et al., 1991), contain
EGF repeats in their protein structures. The EGF-like
repeats of human tenascin-C can function as EGFR ligands
which stimulate EGFR autophosphorylation and induce
mitogenesis in an EGFR-dependent manner (Swindle et
al., 2001). EGFR on astrocytes may function as a receptor
for these guidance molecules and thus participate in the
guidance of axon growth and fasciculation.
Finally, there are striking similarities between our
observations on the mammalian eye and the developmen-
tal regulation by the EGFR pathway in Drosophila eyes
and peripheral nervous system. In Drosophila mela-
nogaster, the retina is sculpted into a pattern of lattice
cells surrounding the photoreceptors in the ommatidia of
the eye. Activation of Drosophila EGFR (dEGFR) by its
ligand, Spitz, is a life signal to lattice cells causing
excessive proliferation that is apparently overcome by a
death signal from Notch causing apoptosis. This mecha-
nism sets the photoreceptor in the precise hexagonal
pattern of lattice cells of the adult eye (Brachmann and
Cagan, 2003). In Drosophila peripheral nervous system
development, the EGFR pathway in glial cells guides
sensory axon pathfinding and is required for the normal
organization of sensory neurons with peripheral glia
(Sepp and Auld, 2003). The use of the EGFR pathway
to organize certain regions of the mammalian neural
system by non-neural cells may have been conserved
throughout phylogeny.Acknowledgments
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